 | • レポートコード：MRC2-11QY01433 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヒト狂犬病ワクチンのグローバル市場について調査・分析したレポートです。種類別（ベロ細胞狂犬病ワクチン、BHK、ニワトリ胚細胞狂犬病ワクチン、その他）市場規模、用途別（暴露前予防、暴露後予防）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒト狂犬病ワクチンの競争状況、市場シェア ・世界のヒト狂犬病ワクチン市場：種類別市場規模 2015年-2020年（ベロ細胞狂犬病ワクチン、BHK、ニワトリ胚細胞狂犬病ワクチン、その他） ・世界のヒト狂犬病ワクチン市場：種類別市場規模予測 2021年-2026年（ベロ細胞狂犬病ワクチン、BHK、ニワトリ胚細胞狂犬病ワクチン、その他） ・世界のヒト狂犬病ワクチン市場：用途別市場規模 2015年-2020年（暴露前予防、暴露後予防） ・世界のヒト狂犬病ワクチン市場：用途別市場規模予測 2021年-2026年（暴露前予防、暴露後予防） ・北米のヒト狂犬病ワクチン市場分析：米国、カナダ ・ヨーロッパのヒト狂犬病ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヒト狂犬病ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヒト狂犬病ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヒト狂犬病ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Sanofi-Pasteur、Chengda、Yisheng、Prcmise、VACN、Changsheng、BCHT、Hissen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Human Rabies Vaccine Market
The global Human Rabies Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Human Rabies Vaccine Scope and Market Size
Human Rabies Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Rabies Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human Rabies Vaccine market is segmented into
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Segment by Application, the Human Rabies Vaccine market is segmented into
Pre-Exposure Prophylaxis
Post-Exposure Prophylaxis
Regional and Country-level Analysis
The Human Rabies Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Rabies Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Rabies Vaccine Market Share Analysis
Human Rabies Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Rabies Vaccine business, the date to enter into the Human Rabies Vaccine market, Human Rabies Vaccine product introduction, recent developments, etc.
The major vendors covered:
Novartis
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
1 Study Coverage
1.1 Human Rabies Vaccine Product Introduction
1.2 Market Segments
1.3 Key Human Rabies Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Rabies Vaccine Market Size Growth Rate by Type
1.4.2 Vero Cell Rabies Vaccine
1.4.3 BHK
1.4.4 Chick Embryo Cell Rabies Vaccine
1.4.5 Others
1.5 Market by Application
1.5.1 Global Human Rabies Vaccine Market Size Growth Rate by Application
1.5.2 Pre-Exposure Prophylaxis
1.5.3 Post-Exposure Prophylaxis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Rabies Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Human Rabies Vaccine Revenue 2015-2026
2.1.2 Global Human Rabies Vaccine Sales 2015-2026
2.2 Global Human Rabies Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Rabies Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Rabies Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Rabies Vaccine Competitor Landscape by Players
3.1 Human Rabies Vaccine Sales by Manufacturers
3.1.1 Human Rabies Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Human Rabies Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Human Rabies Vaccine Revenue by Manufacturers
3.2.1 Human Rabies Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Human Rabies Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Rabies Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Rabies Vaccine Revenue in 2019
3.2.5 Global Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Rabies Vaccine Price by Manufacturers
3.4 Human Rabies Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Human Rabies Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Rabies Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Human Rabies Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Rabies Vaccine Market Size by Type (2015-2020)
4.1.1 Global Human Rabies Vaccine Sales by Type (2015-2020)
4.1.2 Global Human Rabies Vaccine Revenue by Type (2015-2020)
4.1.3 Human Rabies Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Rabies Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Rabies Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Human Rabies Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Human Rabies Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Rabies Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Rabies Vaccine Market Size by Application (2015-2020)
5.1.1 Global Human Rabies Vaccine Sales by Application (2015-2020)
5.1.2 Global Human Rabies Vaccine Revenue by Application (2015-2020)
5.1.3 Human Rabies Vaccine Price by Application (2015-2020)
5.2 Human Rabies Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Rabies Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Human Rabies Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Rabies Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Rabies Vaccine by Country
6.1.1 North America Human Rabies Vaccine Sales by Country
6.1.2 North America Human Rabies Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Rabies Vaccine Market Facts & Figures by Type
6.3 North America Human Rabies Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Human Rabies Vaccine by Country
7.1.1 Europe Human Rabies Vaccine Sales by Country
7.1.2 Europe Human Rabies Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Rabies Vaccine Market Facts & Figures by Type
7.3 Europe Human Rabies Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Rabies Vaccine by Region
8.1.1 Asia Pacific Human Rabies Vaccine Sales by Region
8.1.2 Asia Pacific Human Rabies Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Rabies Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Human Rabies Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Rabies Vaccine by Country
9.1.1 Latin America Human Rabies Vaccine Sales by Country
9.1.2 Latin America Human Rabies Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Rabies Vaccine Market Facts & Figures by Type
9.3 Central & South America Human Rabies Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Rabies Vaccine by Country
10.1.1 Middle East and Africa Human Rabies Vaccine Sales by Country
10.1.2 Middle East and Africa Human Rabies Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Rabies Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Human Rabies Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Human Rabies Vaccine Products Offered
11.1.5 Novartis Related Developments
11.2 Sanofi-Pasteur
11.2.1 Sanofi-Pasteur Corporation Information
11.2.2 Sanofi-Pasteur Description and Business Overview
11.2.3 Sanofi-Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi-Pasteur Human Rabies Vaccine Products Offered
11.2.5 Sanofi-Pasteur Related Developments
11.3 Chengda
11.3.1 Chengda Corporation Information
11.3.2 Chengda Description and Business Overview
11.3.3 Chengda Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Chengda Human Rabies Vaccine Products Offered
11.3.5 Chengda Related Developments
11.4 Yisheng
11.4.1 Yisheng Corporation Information
11.4.2 Yisheng Description and Business Overview
11.4.3 Yisheng Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Yisheng Human Rabies Vaccine Products Offered
11.4.5 Yisheng Related Developments
11.5 Prcmise
11.5.1 Prcmise Corporation Information
11.5.2 Prcmise Description and Business Overview
11.5.3 Prcmise Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Prcmise Human Rabies Vaccine Products Offered
11.5.5 Prcmise Related Developments
11.6 VACN
11.6.1 VACN Corporation Information
11.6.2 VACN Description and Business Overview
11.6.3 VACN Sales, Revenue and Gross Margin (2015-2020)
11.6.4 VACN Human Rabies Vaccine Products Offered
11.6.5 VACN Related Developments
11.7 Changsheng
11.7.1 Changsheng Corporation Information
11.7.2 Changsheng Description and Business Overview
11.7.3 Changsheng Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Changsheng Human Rabies Vaccine Products Offered
11.7.5 Changsheng Related Developments
11.8 BCHT
11.8.1 BCHT Corporation Information
11.8.2 BCHT Description and Business Overview
11.8.3 BCHT Sales, Revenue and Gross Margin (2015-2020)
11.8.4 BCHT Human Rabies Vaccine Products Offered
11.8.5 BCHT Related Developments
11.9 Hissen
11.9.1 Hissen Corporation Information
11.9.2 Hissen Description and Business Overview
11.9.3 Hissen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hissen Human Rabies Vaccine Products Offered
11.9.5 Hissen Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Human Rabies Vaccine Products Offered
11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Rabies Vaccine Market Estimates and Projections by Region
12.1.1 Global Human Rabies Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Human Rabies Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Human Rabies Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Human Rabies Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Human Rabies Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Human Rabies Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Human Rabies Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Human Rabies Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Human Rabies Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Human Rabies Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Rabies Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Rabies Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Rabies Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Rabies Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Rabies Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Rabies Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Human Rabies Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Rabies Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Rabies Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Rabies Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Rabies Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Rabies Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Human Rabies Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Rabies Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Human Rabies Vaccine Market Segments
Table 2. Ranking of Global Top Human Rabies Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Rabies Vaccine Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Vero Cell Rabies Vaccine
Table 5. Major Manufacturers of BHK
Table 6. Major Manufacturers of Chick Embryo Cell Rabies Vaccine
Table 7. Major Manufacturers of Others
Table 8. Global Human Rabies Vaccine Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Human Rabies Vaccine Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Human Rabies Vaccine Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Human Rabies Vaccine Sales Market Share by Regions (2015-2020)
Table 12. Global Human Rabies Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Human Rabies Vaccine Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Human Rabies Vaccine Sales Share by Manufacturers (2015-2020)
Table 15. Global Human Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Human Rabies Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Rabies Vaccine as of 2019)
Table 17. Human Rabies Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Human Rabies Vaccine Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Human Rabies Vaccine Price (2015-2020) (USD/Pcs)
Table 20. Human Rabies Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Human Rabies Vaccine Product Type
Table 22. Date of International Manufacturers Enter into Human Rabies Vaccine Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Human Rabies Vaccine Sales by Type (2015-2020) (K Pcs)
Table 25. Global Human Rabies Vaccine Sales Share by Type (2015-2020)
Table 26. Global Human Rabies Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Human Rabies Vaccine Revenue Share by Type (2015-2020)
Table 28. Human Rabies Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Human Rabies Vaccine Sales by Application (2015-2020) (K Pcs)
Table 30. Global Human Rabies Vaccine Sales Share by Application (2015-2020)
Table 31. North America Human Rabies Vaccine Sales by Country (2015-2020) (K Pcs)
Table 32. North America Human Rabies Vaccine Sales Market Share by Country (2015-2020)
Table 33. North America Human Rabies Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Human Rabies Vaccine Revenue Market Share by Country (2015-2020)
Table 35. North America Human Rabies Vaccine Sales by Type (2015-2020) (K Pcs)
Table 36. North America Human Rabies Vaccine Sales Market Share by Type (2015-2020)
Table 37. North America Human Rabies Vaccine Sales by Application (2015-2020) (K Pcs)
Table 38. North America Human Rabies Vaccine Sales Market Share by Application (2015-2020)
Table 39. Europe Human Rabies Vaccine Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Human Rabies Vaccine Sales Market Share by Country (2015-2020)
Table 41. Europe Human Rabies Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Human Rabies Vaccine Revenue Market Share by Country (2015-2020)
Table 43. Europe Human Rabies Vaccine Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Human Rabies Vaccine Sales Market Share by Type (2015-2020)
Table 45. Europe Human Rabies Vaccine Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Human Rabies Vaccine Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Human Rabies Vaccine Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Human Rabies Vaccine Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Human Rabies Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Human Rabies Vaccine Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Human Rabies Vaccine Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Human Rabies Vaccine Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Human Rabies Vaccine Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Human Rabies Vaccine Sales Market Share by Application (2015-2020)
Table 55. Latin America Human Rabies Vaccine Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Human Rabies Vaccine Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Human Rabies Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Human Rabies Vaccine Revenue Market Share by Country (2015-2020)
Table 59. Latin America Human Rabies Vaccine Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Human Rabies Vaccine Sales Market Share by Type (2015-2020)
Table 61. Latin America Human Rabies Vaccine Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Human Rabies Vaccine Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Human Rabies Vaccine Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Human Rabies Vaccine Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Human Rabies Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Human Rabies Vaccine Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Human Rabies Vaccine Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Human Rabies Vaccine Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Human Rabies Vaccine Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Human Rabies Vaccine Sales Market Share by Application (2015-2020)
Table 71. Novartis Corporation Information
Table 72. Novartis Description and Major Businesses
Table 73. Novartis Human Rabies Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Novartis Product
Table 75. Novartis Recent Development
Table 76. Sanofi-Pasteur Corporation Information
Table 77. Sanofi-Pasteur Description and Major Businesses
Table 78. Sanofi-Pasteur Human Rabies Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Sanofi-Pasteur Product
Table 80. Sanofi-Pasteur Recent Development
Table 81. Chengda Corporation Information
Table 82. Chengda Description and Major Businesses
Table 83. Chengda Human Rabies Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Chengda Product
Table 85. Chengda Recent Development
Table 86. Yisheng Corporation Information
Table 87. Yisheng Description and Major Businesses
Table 88. Yisheng Human Rabies Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Yisheng Product
Table 90. Yisheng Recent Development
Table 91. Prcmise Corporation Information
Table 92. Prcmise Description and Major Businesses
Table 93. Prcmise Human Rabies Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Prcmise Product
Table 95. Prcmise Recent Development
Table 96. VACN Corporation Information
Table 97. VACN Description and Major Businesses
Table 98. VACN Human Rabies Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. VACN Product
Table 100. VACN Recent Development
Table 101. Changsheng Corporation Information
Table 102. Changsheng Description and Major Businesses
Table 103. Changsheng Human Rabies Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Changsheng Product
Table 105. Changsheng Recent Development
Table 106. BCHT Corporation Information
Table 107. BCHT Description and Major Businesses
Table 108. BCHT Human Rabies Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. BCHT Product
Table 110. BCHT Recent Development
Table 111. Hissen Corporation Information
Table 112. Hissen Description and Major Businesses
Table 113. Hissen Human Rabies Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Hissen Product
Table 115. Hissen Recent Development
Table 116. Global Human Rabies Vaccine Sales Forecast by Regions (2021-2026) (K Pcs)
Table 117. Global Human Rabies Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 118. Global Human Rabies Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 119. Global Human Rabies Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 120. North America: Human Rabies Vaccine Sales Forecast by Country (2021-2026) (K Pcs)
Table 121. North America: Human Rabies Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Europe: Human Rabies Vaccine Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Europe: Human Rabies Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Asia Pacific: Human Rabies Vaccine Sales Forecast by Region (2021-2026) (K Pcs)
Table 125. Asia Pacific: Human Rabies Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 126. Latin America: Human Rabies Vaccine Sales Forecast by Country (2021-2026) (K Pcs)
Table 127. Latin America: Human Rabies Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Middle East and Africa: Human Rabies Vaccine Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. Middle East and Africa: Human Rabies Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Human Rabies Vaccine Players
Table 134. Human Rabies Vaccine Customers List
Table 135. Human Rabies Vaccine Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rabies Vaccine Product Picture
Figure 2. Global Human Rabies Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Vero Cell Rabies Vaccine Product Picture
Figure 4. BHK Product Picture
Figure 5. Chick Embryo Cell Rabies Vaccine Product Picture
Figure 6. Others Product Picture
Figure 7. Global Human Rabies Vaccine Sales Market Share by Application in 2020 & 2026
Figure 8. Pre-Exposure Prophylaxis
Figure 9. Post-Exposure Prophylaxis
Figure 10. Human Rabies Vaccine Report Years Considered
Figure 11. Global Human Rabies Vaccine Market Size 2015-2026 (US$ Million)
Figure 12. Global Human Rabies Vaccine Sales 2015-2026 (K Pcs)
Figure 13. Global Human Rabies Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Human Rabies Vaccine Sales Market Share by Region (2015-2020)
Figure 15. Global Human Rabies Vaccine Sales Market Share by Region in 2019
Figure 16. Global Human Rabies Vaccine Revenue Market Share by Region (2015-2020)
Figure 17. Global Human Rabies Vaccine Revenue Market Share by Region in 2019
Figure 18. Global Human Rabies Vaccine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Human Rabies Vaccine Revenue in 2019
Figure 20. Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Human Rabies Vaccine Sales Market Share by Type (2015-2020)
Figure 22. Global Human Rabies Vaccine Sales Market Share by Type in 2019
Figure 23. Global Human Rabies Vaccine Revenue Market Share by Type (2015-2020)
Figure 24. Global Human Rabies Vaccine Revenue Market Share by Type in 2019
Figure 25. Global Human Rabies Vaccine Market Share by Price Range (2015-2020)
Figure 26. Global Human Rabies Vaccine Sales Market Share by Application (2015-2020)
Figure 27. Global Human Rabies Vaccine Sales Market Share by Application in 2019
Figure 28. Global Human Rabies Vaccine Revenue Market Share by Application (2015-2020)
Figure 29. Global Human Rabies Vaccine Revenue Market Share by Application in 2019
Figure 30. North America Human Rabies Vaccine Sales Growth Rate 2015-2020 (K Pcs)
Figure 31. North America Human Rabies Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Human Rabies Vaccine Sales Market Share by Country in 2019
Figure 33. North America Human Rabies Vaccine Revenue Market Share by Country in 2019
Figure 34. U.S. Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.S. Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Human Rabies Vaccine Market Share by Type in 2019
Figure 39. North America Human Rabies Vaccine Market Share by Application in 2019
Figure 40. Europe Human Rabies Vaccine Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. Europe Human Rabies Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Human Rabies Vaccine Sales Market Share by Country in 2019
Figure 43. Europe Human Rabies Vaccine Revenue Market Share by Country in 2019
Figure 44. Germany Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Germany Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. France Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.K. Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Italy Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Russia Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Human Rabies Vaccine Market Share by Type in 2019
Figure 55. Europe Human Rabies Vaccine Market Share by Application in 2019
Figure 56. Asia Pacific Human Rabies Vaccine Sales Growth Rate 2015-2020 (K Pcs)
Figure 57. Asia Pacific Human Rabies Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Human Rabies Vaccine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Human Rabies Vaccine Revenue Market Share by Region in 2019
Figure 60. China Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. China Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. South Korea Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. India Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Australia Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Taiwan Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Indonesia Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Thailand Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Malaysia Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Philippines Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Vietnam Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Human Rabies Vaccine Market Share by Type in 2019
Figure 83. Asia Pacific Human Rabies Vaccine Market Share by Application in 2019
Figure 84. Latin America Human Rabies Vaccine Sales Growth Rate 2015-2020 (K Pcs)
Figure 85. Latin America Human Rabies Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Human Rabies Vaccine Sales Market Share by Country in 2019
Figure 87. Latin America Human Rabies Vaccine Revenue Market Share by Country in 2019
Figure 88. Mexico Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Mexico Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Brazil Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Argentina Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Human Rabies Vaccine Market Share by Type in 2019
Figure 95. Latin America Human Rabies Vaccine Market Share by Application in 2019
Figure 96. Middle East and Africa Human Rabies Vaccine Sales Growth Rate 2015-2020 (K Pcs)
Figure 97. Middle East and Africa Human Rabies Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Human Rabies Vaccine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Human Rabies Vaccine Revenue Market Share by Country in 2019
Figure 100. Turkey Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Turkey Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Saudi Arabia Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Human Rabies Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. U.A.E Human Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Human Rabies Vaccine Market Share by Type in 2019
Figure 107. Middle East and Africa Human Rabies Vaccine Market Share by Application in 2019
Figure 108. North America Human Rabies Vaccine Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 109. North America Human Rabies Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Human Rabies Vaccine Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. Europe Human Rabies Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Human Rabies Vaccine Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Asia Pacific Human Rabies Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Human Rabies Vaccine Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Latin America Human Rabies Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Human Rabies Vaccine Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Middle East and Africa Human Rabies Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
人間用狂犬病ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Rabies Vaccine for Humans Market The global Rabies Vaccine for Humans market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rabies Vaccine for Humans Scope and Market Size Rabies Vaccine …- 狂犬病治療の世界市場（～2026年） Market Analysis and Insights: Global Rabies Treatment Market The global Rabies Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rabies Treatment Scope and Market Size Rabies Treatment market is segmented by Ty…
- ヒトロタウイルスワクチンの世界市場（～2026年） Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease. Rotavirus vaccine is administered by mouth and requires two …
- ヒトパピローマウイルスワクチンの世界市場（～2026年） Human papilloma virus (HPV) vaccine is a vaccine that prevents infection by certain types of human papillomavirus. Market Analysis and Insights: Global Human Papillomavirus Vaccine Market The global Human Papillomavirus Vaccine market size is projected to reach US$ 2220.7 million by 2026, from US$ 2…
- 全細胞コレラワクチンの世界市場（～2026年） Whole Cell Cholera Vaccine is used to prevent Cholera. The factors that fuel the growth of the global whole cell cholera vaccine (recombinant B-subunit) market are rising incidence of cholera among people in endemic regions along with a lack of sanitation and hygiene in certain countries. Market Ana…